Drug treatment of hyperlipidemia in the elderly: HMG-CoA reductase inhibitors and fibric acid derivatives

被引：0
|
作者：
Zambon, A [1 ]
Baggio, G [1 ]
Crepaldi, G [1 ]
机构：
[1] UNIV WASHINGTON,SEATTLE,WA 98195
来源：
DRUGS AFFECTING LIPID METABOLISM: RISK FACTORS AND FUTURE DIRECTIONS | 1996年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：459 / 464
页数：6
相关论文
共 50 条
  • [21] HMG-CoA reductase inhibitors and apoptosis
    Senatore, M
    Buemi, M
    NEPHRON, 1999, 81 (04): : 439 - 440
  • [22] Comparing HMG-CoA reductase inhibitors
    Jones, PH
    CLINICAL CARDIOLOGY, 2003, 26 (01) : I15 - I20
  • [23] HMG-COA REDUCTASE INHIBITORS AND SLEEP
    SPIELBERG, SP
    TOBERT, JA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (01) : 109 - 110
  • [24] Diplopia and HMG-CoA reductase inhibitors
    Fraunfelder, FW
    Fraunfelder, FT
    Edwards, R
    JOURNAL OF TOXICOLOGY-CUTANEOUS AND OCULAR TOXICOLOGY, 1999, 18 (04): : 287 - 289
  • [25] Syntheses of HMG-CoA reductase inhibitors
    Nissan Chemical Industries, Ltd, Chiba, Japan
    Yuki Gosei Kagaku Kyokaishi, 3 (186-196):
  • [26] SYNTHESES OF HMG-COA REDUCTASE INHIBITORS
    MIYACHI, N
    SUZUKI, M
    OHARA, Y
    HIYAMA, T
    JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 1995, 53 (03) : 186 - 196
  • [27] IMIDAZOLES AS HMG-COA REDUCTASE INHIBITORS
    WAREING, JR
    LEGINUS, JM
    SCALLEN, TJ
    LINDER, J
    LEE, GT
    STABLER, R
    MARTIN, M
    WIDLER, L
    MYERS, SW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1988, 196 : 106 - MEDI
  • [28] HMG-CoA reductase inhibitors and myotoxicity
    Ucar, M
    Mjörndal, T
    Dahlqvist, R
    DRUG SAFETY, 2000, 22 (06) : 441 - 457
  • [29] Rhabdomyolysis and HMG-CoA reductase inhibitors
    Omar, MA
    Wilson, JP
    Cox, TS
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (09) : 1096 - 1107
  • [30] HMG-CoA Reductase Inhibitors and Myotoxicity
    Memduh Ucar
    Tom Mjörndal
    Rune Dahlqvist
    Drug Safety, 2000, 22 : 441 - 457
12345